Analystreport

Chromadex Corp (NASDAQ: CDXC) had its "buy" rating re-affirmed by analysts at B. Riley.

ChromaDex Corporation  (CDXC) 
NASDAQ:AMEX Investor Relations: investors.chromadex.com